Clinical Trial

UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma

Name: UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma — clinical trial record (NCT07500805)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-arm, open-label, exploratory clinical study to evaluate the safety and preliminary efficacy of UCL70805F in patients with CD70-positive advanced renal clear cell carcinoma.

Trial Details

NCT Number	NCT07500805
Lead Sponsor	UTC Therapeutics Inc. Collaborators: The First Affiliated Hospital of Zhengzhou University
Conditions	CD70-positive Advanced Renal Clear Cell Carcinoma
Enrollment	21 participants
Start Date	2026-05-01
Primary Completion	2028-05-01 (estimated)
Study Completion	2029-05-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-30